Skip to Content

Cinryze Prices, Coupons and Patient Assistance Programs

Cinryze (C1 esterase inhibitor (human)) is a member of the miscellaneous coagulation modifiers drug class and is commonly used for Hereditary Angioedema.

Cinryze Prices

This Cinryze price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Cinryze intravenous powder for injection 500 units is around $2,889 for a supply of 1 powder for injection, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Intravenous Powder For Injection

500 units Cinryze intravenous powder for injection
from $2,888.74 for 1 powder for injection
Quantity Per unit Price
1 $2,888.74 $2,888.74

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 63,000 pharmacies nationwide.


Cinryze Coupons and Rebates

Cinryze offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Patient Assistance Programs for Cinryze

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: OnePath Patient Assistance Program

Elligibility requirements:

  1. Uninsured or Underinsured with no prescription coverage for needed medication
  2. Not disclosed
  3. Medically appropriate condition/diagnosis
  4. The patient must also be residing in the US.
  5. Program requires a confirmed diagnosis of type 1 Gaucher disease, Hunter syndrome or HAE. Program only covers Shire HGT medications. Sharps Recovery System: Contact program for more detail.

Applicable drugs:

  • Cinryze (C1 esterase inhibitor) Injection
Hide